San Francisco, 10 April 2030: The Report Gene Prediction Tools Market Size, Share & Trends Analysis Report By Type (Software, Services), By Method (Empirical Methods, Ab Initio Methods), By Application (Drug Discovery & Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030
The global gene prediction tools market size was estimated at USD 164.5 million in 2024 and is projected to grow at a CAGR of 18.69% from 2030 to 2030. This growth can be attributed to the increasing R&D in biotechnology and pharmaceuticals, technological advancements in genomics, the growing demand for personalized medicine, and the rising prevalence of genetic disorders. Moreover, growth in government initiatives and funding, and the integration of AI and ML is driving the adoption of gene prediction tools. For instance, in December 2022, the UK government announced to invest around USD 190 million in cutting-edge genomics research to establish the advanced genomic healthcare system.
The growing prevalence of genetic disorders and the need for early diagnosis and intervention drive the demand for gene prediction tools. Accurate gene prediction can facilitate the identification of genetic mutations associated with various diseases, enabling early diagnosis and improved patient outcomes. For instance, genetic disorders such as cystic fibrosis, muscular dystrophy, and certain types of cancer can be better managed with early and precise genetic identification.
The rapid progress in genomic technologies, such as next-generation sequencing (NGS) and bioinformatics, has revolutionized gene prediction. These advancements have enabled more accurate and efficient identification of genes, driving the adoption of gene prediction tools. For instance, the advent of high-throughput sequencing technologies allows for comprehensive analysis of entire genomes, providing vast amounts of data that can be analyzed using sophisticated gene prediction algorithms. By identifying specific genetic variations, healthcare providers can customize treatments for conditions like cancer, cardiovascular diseases, and rare genetic disorders.
Request sample report of Gene Prediction Tools Market@ https://www.grandviewresearch.com/industry-analysis/gene-prediction-tools-market-report/request/rs1
Government initiatives and increased funding for genomic research are also significant drivers for the gene prediction tools industry growth. Governments and research institutions worldwide are investing in genomic projects to advance scientific understanding and improve public health. For instance, the National Institutes of Health (NIH) in the U.S. has funded numerous genomic research initiatives, including the Human Genome Project and the All of Us Research Program. In February 2024, the Australian Government announced the investment of USD 500.1 million in genomic research under the Genomics Health Futures Mission to enhance disease testing and diagnosis, provide personalized treatment options, and improve health outcomes while reducing unnecessary interventions and health costs.
Similarly, in November 2024, the Department of Biotechnology (DBT) and the Biotechnology Research and Innovation Council (BRIC) launched the 'One Day One Genome' initiative to explore India's rich microbial diversity. Shri Amitabh Kant, G-20 Sherpa and former NITI Aayog CEO, announced it during BRIC's first foundation day at the National Institute of Immunology, New Delhi. Such initiatives provide substantial support for the development and adoption of gene prediction tools, fostering market growth.
The market for gene prediction tools is characterized by a high degree of innovation driven by advancements in genomics, bioinformatics, and computational biology. The integration of artificial intelligence (AI) and machine learning (ML) algorithms has significantly enhanced predictive accuracy and the ability to handle large genomic datasets. For instance, AI-driven tools can predict gene functions and interactions more precisely, aiding in the discovery of novel therapeutic targets. Continuous improvements in software algorithms and the incorporation of cloud computing for large-scale genomic data analysis are further propelling innovation in this market.
The gene prediction tools market has witnessed considerable merger and acquisition (M&A) activities, reflecting the strategic efforts of companies to enhance their technological capabilities and expand their market presence. Large biotech and pharmaceutical companies are acquiring smaller, innovative firms to integrate advanced gene prediction technologies into their portfolios.
Key players operating in the gene prediction tools industry are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling the market growth.
